Characterization of factors affecting the release of low-solubility drug from prolonged release tablets

Analytica Chimica Acta

Volumn 502, Issue 1, 2004, Pages 107-113

  Kincl, M ^a   Vrecer F ^a   Veber, M ^b  

^a Lek dd   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Fractional factorial designs; Ionic strengths; pH; Prolonged release tablets; Two level designs

Indexed keywords

ACETIC ACID; COMPOSITION; DISSOLUTION; IONIC STRENGTH; PH EFFECTS; SOLUBILITY; SOLUTIONS; ULTRAVIOLET SPECTROPHOTOMETERS;

AQUEOUS MEDIA; DRUG RELEASE; ROTATION SPEEDS;

DRUG DOSAGE;

DICLOFENAC; NAKLOFEN; SODIUM CHLORIDE;

AQUEOUS SOLUTION; ARTICLE; DISSOLUTION; DRUG RELEASE; DRUG SOLUBILITY; FACTORIAL ANALYSIS; IONIC STRENGTH; LIPOPHILICITY; PH; PRIORITY JOURNAL; ROTATION; TABLET FORMULATION; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0346104871     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2003.09.050     Document Type: Article

References (13)

1. Parojčić J., Durić Z., Jovanović M., Ibrić S., Nikolić L. Pharm. Ind. 63:2001;774.
2. Bloomfield M.S., Butler W.C. Int. J. Pharm. 206:2000;55.
3. E. Demirtürk, C. Eryol, S. Sahin, L. Öner, in: Proceedings of the Fourth World Meeting on Pharmaceutics, Biopharmaceutics, Pharmaceutical Technology, Florence, Italy, April 2002.
4. Homepage of Chemometrics, Introduction to Statistical Experimental Design, July 2003. http://www.acc.umu.se/~tnkjtg/chemometrics .
5. C.M. Adeyeeye, P.K. Li, Analytical profiles of drug substances, in: K. Florey (Ed.), Diclofenac Sodium, vol. 19, Academic Press, New Jersey, 1990, p. 123.
6. Sabnis S., Rege P., Block L.H. Pharm. Dev. Technol. 2:1997;243.
7. Avdeef A., Berger C.M., Brownell C. Pharm. Res. 17:2000;85.
8. USP 26, NF-21, United States Pharmacopeial Convention Inc., Rockville, 2002, p. 2155.
9. Dressman J.B., Amidon G.L., Reppas C., Shah V.P. Pharm. Res. 15(1):1998;11.
10. EMEA, Committee for Proprietary Medicinal Products (CPMP), Note for Guidance on Quality of Modified Release Products, July 1999. http://www.eudra.org/emea.html .
11. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), FDA Guidance for Industry, Extended Release Oral Dosage Forms: Development, Evaluation and Application of In Vitro/In Vivo Correlations, Rockville, September 1997. http://www.fda.gov/ cder/guidance/index.htm .
12. Hörter D., Dressman J.B. Adv. Drug Deliv. Rev. 46:2001;75.
13. S. Bolton, Pharmaceutical Statistics: Practical and Clinical Applications, 2nd ed. (Revised and Expanded), Marcel Dekker, New York, 1990, p. 308.